These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 16770320

  • 1. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.
    Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G.
    Br J Pharmacol; 2006 Aug; 148(7):1022-32. PubMed ID: 16770320
    [Abstract] [Full Text] [Related]

  • 2. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
    Mitchell VA, Greenwood R, Jayamanne A, Vaughan CW.
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
    [Abstract] [Full Text] [Related]

  • 3. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
    Rodella LF, Borsani E, Rezzani R, Ricci F, Buffoli B, Bianchi R.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):139-46. PubMed ID: 15680264
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
    Schreiber AK, Neufeld M, Jesus CH, Cunha JM.
    Neuropharmacology; 2012 Dec 31; 63(8):1286-97. PubMed ID: 22959964
    [Abstract] [Full Text] [Related]

  • 6. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
    Borsani E, Labanca M, Bianchi R, Rodella LF.
    Brain Res; 2007 Jun 04; 1152():87-94. PubMed ID: 17459353
    [Abstract] [Full Text] [Related]

  • 7. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, Cuomo V, Piomelli D.
    Neuropsychopharmacology; 2006 Dec 04; 31(12):2652-9. PubMed ID: 16541083
    [Abstract] [Full Text] [Related]

  • 8. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].
    La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, Cuomo V, Iacono A, Raso GM, Meli R, Piomelli D, Calignano A.
    J Pharmacol Exp Ther; 2006 Jun 04; 317(3):1365-71. PubMed ID: 16510698
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
    Haranishi Y, Hara K, Terada T.
    Pharmacol Rep; 2021 Jun 04; 73(3):820-827. PubMed ID: 33783763
    [Abstract] [Full Text] [Related]

  • 10. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.
    Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G, Sadile AG, Giuffrida A, Piomelli D.
    J Neurosci; 2000 May 01; 20(9):3401-7. PubMed ID: 10777802
    [Abstract] [Full Text] [Related]

  • 11. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J.
    Neurobiol Dis; 2005 Nov 01; 20(2):207-17. PubMed ID: 16242629
    [Abstract] [Full Text] [Related]

  • 12. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
    Trezza V, Vanderschuren LJ.
    J Pharmacol Exp Ther; 2009 Jan 01; 328(1):343-50. PubMed ID: 18948500
    [Abstract] [Full Text] [Related]

  • 13. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
    Kelley BG, Thayer SA.
    Eur J Pharmacol; 2004 Aug 02; 496(1-3):33-9. PubMed ID: 15288572
    [Abstract] [Full Text] [Related]

  • 14. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
    Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S.
    Eur J Neurosci; 2006 Oct 02; 24(7):2011-20. PubMed ID: 17040473
    [Abstract] [Full Text] [Related]

  • 15. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats.
    Roche M, Kelly JP, O'Driscoll M, Finn DP.
    Immunology; 2008 Oct 02; 125(2):263-71. PubMed ID: 18393970
    [Abstract] [Full Text] [Related]

  • 16. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.
    Ortega-Gutiérrez S, Molina-Holgado E, Guaza C.
    Glia; 2005 Nov 01; 52(2):163-8. PubMed ID: 15920730
    [Abstract] [Full Text] [Related]

  • 17. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
    Jonsson KO, Andersson A, Jacobsson SO, Vandevoorde S, Lambert DM, Fowler CJ.
    Arch Toxicol; 2003 Apr 01; 77(4):201-7. PubMed ID: 12698235
    [Abstract] [Full Text] [Related]

  • 18. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve.
    Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T.
    Pain; 2005 Jul 01; 116(1-2):52-61. PubMed ID: 15936882
    [Abstract] [Full Text] [Related]

  • 19. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response.
    Wang W, Mei XP, Chen L, Tang J, Li JL, Wu SX, Xu LX, Li YQ.
    Pain Physician; 2012 Jul 01; 15(6):E995-1006. PubMed ID: 23159984
    [Abstract] [Full Text] [Related]

  • 20. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
    Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulié P, Piomelli D.
    Eur J Pharmacol; 2000 Nov 17; 408(2):161-8. PubMed ID: 11080522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.